Transilwrap Company Inc, a value-added manufacturer, converter and distributor of specialty film products used in healthcare, packaging, point-of purchase, display advertising, security identification, protective and industrial markets, has signed an agreement on March 31, 2016 to acquire Dow Chemical Company’s global specialty films business.
Dow’s specialty films business has over 50 years of expertise in providing film solutions used in medical, packaging and industrial markets and specialises in the production of blown oriented polystyrene films and co-extruded multilayer barrier and polyolefin films for global customers, through manufacturing facilities in Hebron, Ohio and Drusenheim, France. The business is an industry pioneer for many medical and packaging applications and is considered the leading global producer of high-value and technically complex medical films for ostomy bags. In packaging and industrial segments, specialty films business offers brands such as Saranex barrier films, Procite films and Opticite films across many applications including beverage closure liners, ostomy appliances, window envelope films, labels and protective fabrics.
“Dow’s film technologies, market focus and geographic presence support accelerated growth and global expansion in Transilwrap’s strategic market segments including healthcare and packaging. Dow’s specialty films business is well regarded in the industry for strong technical expertise and globally recognised brands associated with quality, reliability and leadership and we look forward to working with their existing management team to drive new business opportunities forward,” said Andy Brewer, president & CEO of Transilwrap.
In November 2013, the Jordan Company, in partnership with the existing management team, acquired Transilwrap as a platform to build a leading global specialty films company. Dow’s specialty films business represents a meaningful acquisition under Jordan’s ownership as it supports accelerated growth and global expansion in Transilwrap’s strategic market segments.